Home › Companies › VIKING THERAPEUTICS INC. › 2023-2024
Compiled from SEC Form N-PX filings and VIKING THERAPEUTICS INC.’s Form 8-K, filed 2024-05-23 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore VIKING THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are VIKING THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-05-23 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Brian Lian, Ph.D. | 50,502,615 | -- | -- | 17,436,415 | 20,260,462 | Majority: yes |
| Elect Director: Lawson Macartney, Ph.D. | 22,267,255 | -- | -- | 45,671,775 | 20,260,462 | Plurality election |
| Proposal 2: . To ratify the selection of Marcum LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2024: | 87,382,144 | 743,579 | 73,767 | -- | -- | Majority: yes |
| Proposal 3: . To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement: | 63,234,707 | 4,510,461 | 193,862 | -- | 20,260,462 | Majority: yes |
| Proposal 4: . To approve the 2024 EIP: | 48,547,615 | 19,279,010 | 112,405 | -- | 20,260,462 | Majority: yes |
| Proposal 5: . To approve the 2024 ESPP: | 67,119,655 | 734,042 | 85,333 | -- | 20,260,462 | Majority: yes |
Source: VIKING THERAPEUTICS INC., Form 8-K, filed with the SEC on 2024-05-23 — read the filing on EDGAR.
Each item below shows how the 376 asset managers that disclosed a VIKING THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of VIKING THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held 2024-05-21.
Combines 16 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
VIKING THERAPEUTICS INC.’s own tally for this item (“Proposal 3: . To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement:”): 63,234,707 for, 4,510,461 against, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 110,228,869 outstanding shares: 57% for, 4% against (61% of the company cast a for/against vote).
The 368 asset managers below cast 94% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 28,511,068 | 0 | 0 | 0 | For |
| Vanguard | 7,969,719 | 0 | 0 | 0 | For |
| BlackRock | 6,350,371 | 14,865 | 0 | 0 | For |
| State Street | 4,052,549 | 571 | 0 | 0 | For |
| AllianceBernstein | 2,008,425 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,841,944 | 0 | 0 | 0 | For |
| Charles Schwab | 1,694,359 | 0 | 0 | 0 | For |
| American Century | 0 | 1,529,115 | 0 | 0 | Against |
| Voya | 1,352,064 | 0 | 0 | 0 | For |
| JPMorgan | 1,249,320 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 1,234,936 | 0 | 0 | 0 | For |
| VIKING GLOBAL INVESTORS LP | 1,094,940 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 818,055 | 0 | 0 | 0 | For |
| Invesco | 772,062 | 0 | 0 | 0 | For |
| Avoro Capital Advisors LLC | 673,864 | 0 | 0 | 0 | For |
| Putnam | 636,197 | 0 | 0 | 0 | For |
| Northern Trust | 624,637 | 73 | 0 | 0 | For |
| Clearbridge Investments, LLC | 596,976 | 0 | 0 | 0 | For |
| Citadel | 563,735 | 0 | 0 | 0 | For |
| Victory Capital | 546,988 | 0 | 0 | 0 | For |
| Nuveen | 491,460 | 0 | 0 | 0 | For |
| BAMCO INC /NY/ | 0 | 480,173 | 0 | 0 | Against |
| BRAIDWELL LP | 470,839 | 0 | 0 | 0 | For |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 463,501 | 0 | 0 | 0 | For |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 441,228 | 21,987 | 0 | 0 | For |
Showing the 25 largest of 368 asset managers. See all 368 in the interactive database.
Meeting held 2024-05-21.
Combines 3 wordings of this item as funds reported it.
99.1% fund support · no official result
The 110 asset managers below cast 99.1% of the shares they voted on this item FOR (35,457,083 for, 312,110 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 12,164,231 | 0 | 0 | 0 | For |
| Vanguard | 7,702,135 | 0 | 0 | 0 | For |
| BlackRock | 3,600,224 | 0 | 0 | 0 | For |
| State Street | 1,047,576 | 0 | 0 | 0 | For |
| Charles Schwab | 838,984 | 0 | 0 | 0 | For |
| American Century | 769,898 | 0 | 0 | 0 | For |
| Voya | 611,073 | 0 | 0 | 0 | For |
| JPMorgan | 577,597 | 0 | 0 | 0 | For |
| AllianceBernstein | 568,931 | 0 | 0 | 0 | For |
| TIAA | 411,560 | 0 | 0 | 0 | For |
| Invesco | 351,183 | 0 | 0 | 0 | For |
| Legg Mason | 345,200 | 0 | 0 | 0 | For |
| Equitable | 336,330 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 336,235 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 316,600 | 0 | 0 | 0 | For |
| Principal | 315,077 | 0 | 0 | 0 | For |
| Putnam | 311,905 | 0 | 0 | 0 | For |
| Lord Abbett | 277,398 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 269,469 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 267,893 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 266,975 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 252,485 | 0 | 0 | 0 | For |
| MFS | 0 | 251,577 | 0 | 0 | Against |
| Victory Capital | 243,208 | 0 | 0 | 0 | For |
| Jackson National | 238,241 | 0 | 0 | 0 | For |
Showing the 25 largest of 110 asset managers. See all 110 in the interactive database.
Meeting held 2024-05-21.
Combines 3 wordings of this item as funds reported it.
79% fund support · no official result
The 110 asset managers below cast 79% of the shares they voted on this item FOR (28,155,855 for, 7,606,377 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 12,124,513 | 39,718 | 0 | 0 | For |
| Vanguard | 7,702,135 | 0 | 0 | 0 | For |
| BlackRock | 3,600,224 | 0 | 0 | 0 | For |
| State Street | 1,032 | 1,046,544 | 0 | 0 | Against |
| Charles Schwab | 838,984 | 0 | 0 | 0 | For |
| American Century | 0 | 769,898 | 0 | 0 | Against |
| Voya | 0 | 611,073 | 0 | 0 | Against |
| JPMorgan | 577,597 | 0 | 0 | 0 | For |
| AllianceBernstein | 568,931 | 0 | 0 | 0 | For |
| TIAA | 0 | 411,560 | 0 | 0 | Against |
| Invesco | 351,183 | 0 | 0 | 0 | For |
| Legg Mason | 345,200 | 0 | 0 | 0 | For |
| Equitable | 336,330 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 336,235 | 0 | 0 | Against |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 0 | 316,600 | 0 | 0 | Against |
| Principal | 201,278 | 113,799 | 0 | 0 | For |
| Putnam | 0 | 311,905 | 0 | 0 | Against |
| Lord Abbett | 0 | 277,398 | 0 | 0 | Against |
| MUTUAL FUND SERIES TRUST | 16,500 | 252,969 | 0 | 0 | Against |
| AB DISCOVERY GROWTH FUND, INC. | 267,893 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 266,975 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 252,485 | 0 | 0 | Against |
| MFS | 0 | 251,577 | 0 | 0 | Against |
| Victory Capital | 0 | 243,208 | 0 | 0 | Against |
| Jackson National | 140,222 | 98,019 | 0 | 0 | For |
Showing the 25 largest of 110 asset managers. See all 110 in the interactive database.
Meeting held 2024-05-21.
Combines 3 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
VIKING THERAPEUTICS INC.’s own tally for this item (“Proposal 2: . To ratify the selection of Marcum LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2024:”): 87,382,144 for, 743,579 against, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 110,228,869 outstanding shares: 79% for, 0.7% against (80% of the company cast a for/against vote).
The 107 asset managers below cast 99.9% of the shares they voted on this item FOR (35,748,182 for, 164 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 12,164,231 | 0 | 0 | 0 | For |
| Vanguard | 7,702,135 | 0 | 0 | 0 | For |
| BlackRock | 3,600,224 | 0 | 0 | 0 | For |
| State Street | 1,047,412 | 164 | 0 | 0 | For |
| Charles Schwab | 838,984 | 0 | 0 | 0 | For |
| American Century | 769,898 | 0 | 0 | 0 | For |
| Voya | 611,073 | 0 | 0 | 0 | For |
| JPMorgan | 577,597 | 0 | 0 | 0 | For |
| AllianceBernstein | 568,931 | 0 | 0 | 0 | For |
| TIAA | 411,560 | 0 | 0 | 0 | For |
| Invesco | 351,183 | 0 | 0 | 0 | For |
| Legg Mason | 345,200 | 0 | 0 | 0 | For |
| Equitable | 336,330 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 336,235 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 316,600 | 0 | 0 | 0 | For |
| Principal | 315,077 | 0 | 0 | 0 | For |
| Putnam | 311,905 | 0 | 0 | 0 | For |
| Lord Abbett | 277,398 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 269,469 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 267,893 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 266,975 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 252,485 | 0 | 0 | 0 | For |
| MFS | 251,577 | 0 | 0 | 0 | For |
| Victory Capital | 243,208 | 0 | 0 | 0 | For |
| Jackson National | 238,241 | 0 | 0 | 0 | For |
Showing the 25 largest of 107 asset managers. See all 107 in the interactive database.
Meeting held 2024-05-21.
Combines 8 wordings of this item as funds reported it.
74% Majority: yes · of votes cast
VIKING THERAPEUTICS INC.’s own tally for this item (“Elect Director: Brian Lian, Ph.D.”): 50,502,615 for, 17,436,415 withheld, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 110,228,869 outstanding shares: 45.8% for, 16% withheld (62% of the company cast a for/withheld vote).
The 106 asset managers below cast 100% of the shares they voted on this item FOR (25,099,078 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 1,799,363 | 0 | 10,364,868 | 0 | Abstain |
| Vanguard | 7,702,135 | 0 | 0 | 0 | For |
| BlackRock | 3,600,224 | 0 | 0 | 0 | For |
| State Street | 1,047,464 | 0 | 112 | 0 | For |
| Charles Schwab | 838,984 | 0 | 0 | 0 | For |
| American Century | 769,898 | 0 | 0 | 0 | For |
| Voya | 611,073 | 0 | 0 | 0 | For |
| JPMorgan | 577,597 | 0 | 0 | 0 | For |
| AllianceBernstein | 568,931 | 0 | 0 | 0 | For |
| TIAA | 411,560 | 0 | 0 | 0 | For |
| Invesco | 351,183 | 0 | 0 | 0 | For |
| Legg Mason | 345,200 | 0 | 0 | 0 | For |
| Equitable | 336,330 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 336,235 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 316,600 | 0 | 0 | 0 | For |
| Principal | 232,360 | 0 | 82,717 | 0 | For |
| Putnam | 311,905 | 0 | 0 | 0 | For |
| Lord Abbett | 277,398 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 269,469 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 267,893 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 266,975 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 252,485 | 0 | 0 | 0 | For |
| MFS | 251,577 | 0 | 0 | 0 | For |
| Victory Capital | 243,208 | 0 | 0 | 0 | For |
| Jackson National | 236,307 | 0 | 1,934 | 0 | For |
Showing the 25 largest of 106 asset managers. See all 106 in the interactive database.
Meeting held 2024-05-21.
Combines 8 wordings of this item as funds reported it.
33% Plurality election · of votes cast
VIKING THERAPEUTICS INC.’s own tally for this item (“Elect Director: Lawson Macartney, Ph.D.”): 22,267,255 for, 45,671,775 withheld, per its Form 8-K filed 2024-05-23 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here. Of all 110,228,869 outstanding shares: 20% for, 41% withheld (62% of the company cast a for/withheld vote).
The 106 asset managers below cast 99.9% of the shares they voted on this item FOR (11,425,236 for, 30 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 1,697,041 | 0 | 10,467,190 | 0 | Abstain |
| Vanguard | 7,513,035 | 0 | 189,100 | 0 | For |
| BlackRock | 0 | 0 | 3,600,224 | 0 | Abstain |
| State Street | 1,032 | 0 | 1,046,544 | 0 | Abstain |
| Charles Schwab | 0 | 0 | 838,984 | 0 | Abstain |
| American Century | 0 | 0 | 769,898 | 0 | Abstain |
| Voya | 0 | 0 | 611,073 | 0 | Abstain |
| JPMorgan | 577,597 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 0 | 568,931 | 0 | Abstain |
| TIAA | 0 | 0 | 411,560 | 0 | Abstain |
| Invesco | 0 | 0 | 351,183 | 0 | Abstain |
| Legg Mason | 0 | 0 | 345,200 | 0 | Abstain |
| Equitable | 0 | 0 | 336,330 | 0 | Abstain |
| Delaware/Macquarie | 0 | 0 | 336,235 | 0 | Abstain |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 0 | 0 | 316,600 | 0 | Abstain |
| Principal | 163 | 0 | 314,914 | 0 | Abstain |
| Putnam | 311,905 | 0 | 0 | 0 | For |
| Lord Abbett | 277,398 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 269,469 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 0 | 0 | 267,893 | 0 | Abstain |
| Columbia Threadneedle | 0 | 0 | 266,975 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 252,485 | 0 | Abstain |
| MFS | 0 | 0 | 251,577 | 0 | Abstain |
| Victory Capital | 0 | 0 | 243,208 | 0 | Abstain |
| Jackson National | 0 | 0 | 238,241 | 0 | Abstain |
Showing the 25 largest of 106 asset managers. See all 106 in the interactive database.
Meeting held 2025-05-20 (outside the 2023-2024 season's 1 July to 30 June window; reported in this season's filings).
67% Majority: yes · of votes cast
VIKING THERAPEUTICS INC.’s own tally for this item (“Proposal 3: . To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement:”): 29,265,273 for, 14,490,719 against, per its Form 8-K filed 2025-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 110,228,869 outstanding shares: 27% for, 13% against (40% of the company cast a for/against vote).
The 4 asset managers below cast 0.1% of the shares they voted on this item FOR (91 for, 231,247 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| 683 Capital Management, LLC | 0 | 231,247 | 0 | 0 | Against |
| MBA Advisors LLC | 50 | 0 | 0 | 0 | For |
| Foster Victor Wealth Advisors, LLC | 23 | 0 | 0 | 0 | For |
| First County Bank /CT/ | 18 | 0 | 0 | 0 | For |
Meeting held 2024-05-21.
99% fund support · no official result
The 2 asset managers below cast 99% of the shares they voted on this item FOR (10,817 for, 129 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BOSUN ASSET MANAGEMENT, LLC | 10,817 | 0 | 0 | 0 | For |
| ZIMMERMANN INVESTMENT MANAGEMENT & PLANNING LLC | 0 | 129 | 0 | 0 | Against |
Meeting held 2024-05-21.
All nominees (reported as one line). These filers reported the election of directors as a single line covering every nominee. It is not attributed to any one director, and no share total is shown for it.
100% fund support · no official result
The 2 asset managers below cast 100% of the shares they voted on this item FOR.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Northern Lights Fund Trust IV | 18,737 | 0 | 0 | 0 | For |
| ETF Opportunities Trust | 4,273 | 0 | 0 | 0 | For |
Meeting held 2024-05-21.
99.1% Majority: yes · of votes cast
VIKING THERAPEUTICS INC.’s own tally for this item (“Proposal 2: . To ratify the selection of Marcum LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2024:”): 87,382,144 for, 743,579 against, per its Form 8-K filed 2024-05-23 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 110,228,869 outstanding shares: 79% for, 0.7% against (80% of the company cast a for/against vote).
The 2 asset managers below cast 100% of the shares they voted on this item FOR (1,266 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Northern Lights Fund Trust IV | 1,137 | 0 | 0 | 0 | For |
| ZIMMERMANN INVESTMENT MANAGEMENT & PLANNING LLC | 129 | 0 | 0 | 0 | For |
Ranked by the number of VIKING THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 110,228,869 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 25.87% |
| 2 | Vanguard | 7.23% |
| 3 | BlackRock | 5.77% |
| 4 | State Street | 3.68% |
| 5 | AllianceBernstein | 1.82% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 1.67% |
| 7 | Charles Schwab | 1.54% |
| 8 | American Century | 1.39% |
| 9 | Voya | 1.23% |
| 10 | JPMorgan | 1.13% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| FMR LLC | 13.61% | DEF14A |
| Vanguard Group | 9.07% | 13F |
| FMR (Fidelity) | 5.25% | 13F |
| BlackRock | 5.08% | 13F |
| Entities Associated with Viking Global Investors LP | 4.67% | DEF14A |
| Morgan Stanley | 3.38% | 13F |
| Brian Lian, Ph.D. | 3.09% | DEF14A |
| State Street | 3.02% | 13F |
| Citadel Advisors | 2.83% | 13F |
| JPMorgan Chase | 2.34% | 13F |
Percentages above are of 110,228,869 shares outstanding, as reported by VIKING THERAPEUTICS INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from VIKING THERAPEUTICS INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At VIKING THERAPEUTICS INC.'s shareholder meeting held 2024-05-21, in the 2023-2024 proxy season, 376 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,516 separate fund positions. Their filings are grouped here into 10 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of our named executive officers. — FOR was 93% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: VIKING THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-05-23.
VIKING THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.